MIPS 2022—What’s New With Improvement Activities
Excerpted from “MIPS—What’s New for 2022, Part 1: Scoring, Bonuses, and Penalties” (EyeNet, January 2022). Also see, EyeNet’s MIPS Manual 2022: A Primer and Reference.
The improvement activities performance category is largely the same as in previous years, though some activities have been removed and others have been revised.
CMS has removed some improvement activities. A few of the improvement activities that had been most relevant to ophthalmology will no longer be available in 2022:
- IA_BE_13: Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms. This activity has been removed because CMS said that it is duplicative of IA_BE_6: Collection and follow-up on patient experience and satisfaction data on beneficiary engagement.
- IA_BE_17: Use of tools to assist patient self-management. This activity has been removed because CMS said that it is duplicative of IA_BE_16: Evidence-based techniques to promote self-management into usual care.
- IA_PSPA_11: Participation in CAHPS or other supplemental questionnaire. This activity has been removed because CMS said that it is duplicative of IA_BE_6.
CMS made changes to several improvement activities. Of the improvement activities that are most relevant to ophthalmology, activities that have undergone changes include the following:
- IA_AHE_1: Engagement of new Medicaid patients and follow-up
- IA_AHE_5: MIPS eligible clinician leadership in clinical trials or CBPR [community-based participatory research]
- IA_BE_1: Use of certified EHR to capture patient reported outcomes
- IA_BE_6: Collection and follow-up on patient experience and satisfaction data on beneficiary engagement
- IA_BE_16: Evidence-based techniques to promote self-management into usual care
- IA_CC_14: Practice improvements that engage community resources to support patient health goals
- IA_EPA_1: Provide 24/7 access to MIPS eligible clinicians or groups who have real-time access to patient’s medical record
- IA_EPA_2: Use of telehealth services that expand practice access
- IA_PM_6: Use of toolsets or other resources to close healthcare disparities across communities
- IA_PM_11: Regular review practices in place on targeted patient population needs
- IA_PSPA_6: Consultation of the Prescription Drug Monitoring Program
- IA_PSPA_18: Measurement and improvement at the practice and panel level
Previous: MIPS 2022—What’s New With Promoting Interoperability
Next: MIPS 2022—What’s New With Cost
DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.
COPYRIGHT© 2022, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology®.